[Intranasal vaccination with live measles vaccines within the framework of measles eradication strategy].

The authors discuss the possibility of intranasal revaccination with live measles vaccine. Intranasal vaccination is no less effective than subcutaneous. It induces generalized immune response and formation of anti-measles IgA in the nasopharyngeal mucosa.

[Efficiency of revaccination against epidemic parotitis and immunological safety].

Seventy-eight children aged 6-7 years were subcutaneously revaccinated with L-3 live mumps vaccine. The vaccine is slightly reactogenic and completely safe. The level of antibodies increased on day 10 postvaccination in 80% of children with initially low antibody titers.

[Possibilities of measles vaccination in children with counterindications and duration of preservation of postvaccinal immunity].

A study was made of the clinicoimmunological reactions in 2056 children with different somatic diseases, in children frequently falling ill and in those with tuberculous infection vaccinated against measles. Of these, 912 children were vaccinated after carrying out the treatment and health measures and 1144 children remained without those measures; 192 practically healthy children were vaccinated with the same series of vaccines. The treatment and health measures carried out before vaccination decrease the rate and intensity of the clinical manifestations of the measles vaccinal process and enhance antibody formation.

[Septic metastatic staphylococcal destruction of the lungs in adults].

The author analyzes results of diagnostics and treatment of 152 patients with septic metastatic staphylococcal destruction of the lungs. Specific features of the clinical course of the disease are described. Under consideration are questions of the complex pathogenetic treatment of this group of patients by means of using antibiotic and immune therapy, fat emulsions (lipofundin), exchange plasmapheresis, ultraviolet irradiation of blood etc.